Angiotensin II Type 2 Receptor Expression Affects Remodeling after Myocardial Infarction in Mice

スポンサーリンク

概要

• 論文の詳細を見る
• 社団法人日本循環器学会の論文
• 2003-03-01

著者

• Horiuchi Masatsugu

  Department of Medical Biochemistry 1, Ehime University School of Medicine

• Okamoto Hiroshi

  Department Of Cardiovascular Medicine Hokkaido University Hospital

• Matsui Yutaka

  Department Of Cardiovascular Medicine Graduate School Of Medicine Hokkaido University

• Kitabatake Akira

  Department of Cardiovascular Medicine, Graduate School of Medicine, Hokkaido University

• Akino Masatoshi

  Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

• Sugawara Takeshi

  Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

• SHIMIZU Toshihiro

  Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

• CHIBA Satoru

  Department of Cardiovascular Medicine, Hokkaido University Graduate School of Medicine

• Chiba Satoru

  Department Of Cardiovascular Medicine Kushiro Rousai Hospital

• Sugawara Takeshi

  Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine

• Shimizu Toshihiro

  Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medical Sciences

• Akino Masatoshi

  Hokkou Kinenn Hospital

• Onozuka Hisao

  北海道大学 医学研究科循環病態内科学

• Chiba S

  Department Of Cardiovascular Medicine Kushiro Rousai Hospital

• Horiuchi Masatsugu

  Department Of Biochemistry Ehime University School Of Medicine

• Sugawara Takeshi

  Department Of Anesthesiology Faculty Of Medicine University Of Yamanashi

• Kitabatake Akira

  Department Of Cardicvascular Medicine Hokkaidou University

• Akino Masatoshi

  Department Of Cardiovascular Medicine Hokkaido University Graduate School Of Medicine

• Matsui Yutaka

  Department Of Applied Chemistry And Biotechnology Faculty Of Engineering Fukui University

• Shimizu Toshihiro

  Department Of Applied Physics School Of Science And Engineering Waseda University

• Okamoto Hiroshi

  Department Of Advanced Materials Science Graduate School Of Frontier Sciences University Of Tokyo:cr

• Okamoto Hiroshi

  Department Of Advanced Biological Sciences For Regeneration (kotobiken Medical Laboratories) Tohoku

• Okamoto Hiroshi

  Departments Of Cardiovascular Medicine Graduate School Of Medicine Hokkaido University

• OKAMOTO Hiroshi

  NHO Hokkaido Medical Center

• Shimizu Toshihiro

  Department of Applied Fine Chemistry, Faculty of Engineering, Osaka University

関連論文

• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Devil and angel in the renin-angiotensin system : ACE-angiotensin II-AT_1 receptor axis vs. ACE2-angiotensin-(1-7)-Mas receptor axis
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• 1 Pharmacogenomics of β-blocker Therapy in Chronic Heart Failure(New Approaches to Heart Failure-from Pharmacogenomics to Drug Development, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Which is most Beneficial for Preserving Cardiac Function and Coronary Microvasculaturein DCM, ACE-I, ARB or Two in Combination? (Cardiac Hypertrophy/Cardiomyopathy 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Eplerenone Prevents Cardiac Fibrosis through the Inhibition of OPN Expression (Cardiac Hypertrophy, Basic (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Osteopontin is Essential for Angiotensin II-Induced Cardiac Fibrosis(Heart Failure, Basic 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• A Newly Developed Angiotensin II Type 1 Receptor Antagonist, CS866, Promotes Regression of Cardiac Hypertrophy by Reducing Integrin β_1 Expression
• Angiogenesis Is Altered by Angiotensin Type 1 Receptor Blockade in Cardiomyopathic Hamster Hearts
• Angiotensin II Type 2 Receptor Expression Affects Remodeling after Myocardial Infarction in Mice
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Blockade of T-cell costimulatory signals using adenovirus vectors attenuates experimental autoimmune myocarditis through the induction of antigen-specific T-cell anergy
• The Chronic Effect of Amlodipine on Cardiac Remodeling in Cardiomyopathic Hamster Hearts
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• Coronary microvasculature is related with cardiac remodeling in cardiomyopathic hearts
• Development of Atherosclerosis in Osteopontin Transgenic Mice
• Immunosuppressive Therapy in Refractory Heart Failure : Blockade of T Cell Costimulatory Signals
• Role of Microvasculature in Cardiac Remodeling Process
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-376 Bone Marrow AT1 and AT2 Differentially Modulate Vascular Repair by Regulating Mobilization of Bone Marrow-derived c-Kit^-Sca-1^+Lin^- Progenitors via SDF-1 α/CXCR4 Axis(Restenosis basic/clinical(04)(IHD),Poster Session(Japanese),The 72nd Annual Sci
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• The study of bone mineral density and bone turnover markers in postmenopausal women with active rheumatoid arthritis
• PJ-376 Bone Marrow AT1 and AT2 Differentially Modulate Vascular Repair by Regulating Mobilization of Bone Marrow-derived c-Kit^-Sca-1^+Lin^- Progenitors via SDF-1 α/CXCR4 Axis(Restenosis basic/clinical(04)(IHD),Poster Session(Japanese),The 72nd Annual Sci
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• Inhibition of Inward Rectifier K^+ Currents by Angiotensin II in Rat Atrial Myocytes : Lack of Effects in Cells from Spontaneously Hypertensive Rats
• Effects of Angiotensin II on the Action Potential Durations of Atrial Myocytes in Hypertensive Rats
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• Improvement of glucose intolerance by combination of pravastatin and olmesartan in type II diabetic KK-A^y mice
• Complete Freund's Adjuvant Can Activate TLR2 and Suppress Cardiac Necrosis in Cardiomyopathic Heart
• Complete Freund's Adjuvant can Suppress Cardiac Remodeling in Cardiomyopathic Heart, and Induce Pulmonary Granulomas
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• PJ-635 Effect of Olmesartan on Tissue Expression Balance between Angiotensin II Receptor and Its Inhibitory Binding Molecule(PJ107,Cardiomyopathy/Hypertrophy (Basic, Clinical) (M),Poster Session (Japanese),The 73rd Annual Scientific Meeting of The Japanes
• PJ-643 Tissue-Specific Regulation of ATRAP, A Novel Interacting Molecule with AT1 Receptor, in Spontaneously Hypertensive Rats(Hypertension, basic-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• Overexpression of human CD38/ADP-ribosyl cyclase enhances acetylcholine-induced Ca^ signalling in rodent NG108-15 neuroblastoma cells
• Essential Role of Angiotensin II Type 1a Receptors in the Host Vascular Wall, but Not the Bone Marrow, in the Pathogenesis of Angiotensin II-Induced Atherosclerosis
• PE-037 An Essential Role of Angiotensin II Type 1 Receptor in Arterial Wall, Not in Bone Marrow, in Angiotensin II-Induced Atherosclerosis(Atherosclerosis, basic-4, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-026 Angiotensin II Type2 Receptor in Bone Marrow-Derived Cells Inhibits Neointimal Hyperplasia by Counteracting Type1 Receptor Function in Mouse Wire-Injured Artery(Restenosis, basic/clinical-1 (IHD) OJ5,Oral Presentation (Japanese),The 70th Anniversar
• Valsartan Inhibits Coronary Intimal Hyperplasia after Directional Coronary Atherectomy (Restenosis after Angioplasty, Basic/Clinical 3 (IHD), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Anti-Aging Medicine in Cardiovascular Disease
• Quantitative Assessment of Regional Myocardial Blood Flow and Myocardial Flow Reserve Using Tc-99m-sestamibi Imaging(Nuclear Cardiology 4 (I), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Assessment of Myocardial Beta-adrenergic Receptor Density in Patients with Congestive Heart Failure : PET Study with C-11-labeled-CGP-12177(Nuclear Cardiology 6 (I), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• Quantitative Assessment of Regional Myocardial Flow Reserve Using Tc-99m-Sestamibi Imaging : Comparison With Results of O-15 Water PET
• Evaluation of Effects of Polymorphism for Metabolic Enzymes on Pharmacokinetics of Carvedilol by Population Pharmacokinetic Analysis(Biopharmacy)
• The Studies of Cell Damaging and Cell Growth Factors which Induce Cardiomyopathy : MOLECULAR ANALYSIS OF THE PATHOPHYSIOLOGY OF CARDIOMYPATHY
• PHOSPHATIDYLINOSITOL AND INOSITOLPHOSPHATIDE METABOLISM IN HYPERTROPHIED RAT HEART
• Role of renin-angiotensin system in adipose tissue dysfunction
• Inhibition of the renin-angiotensin system and target organ protection
• Attenuation of Focal Brain Ischemia by Telmisartan, an Angiotensin II Type 1 Receptor Blocker, in Atherosclerotic Apolipoprotein E-Deficient Mice
• Akt-FOXO3a Signaling Affects Human Endothelial Progenitor Cell Differentiation
• Role of NAD(P)H Oxidase and Its Regulation in Chronic Hypertension
• Regression of Atherosclerosis by Amlodipine via Anti-Inflammatory and Anti-Oxidative Stress Actions
• Signaling Crosstalk Angiotensin II Receptor Subtypes and Insulin
• The Role of Tumor Necrosis Factor-α in Inducing Insulin Resistance in the Renin-Angiotensin System
• OE-117 Eplerenone, a Selective Aldosterone Receptor Antagonist, Inhibits Atherosclerotic Lesion Formation in Apolipoprotein E-Deficient Mice(Atherosclerosis, Basic 1 (IHD) : OE14)(Oral Presentation (English))
• Role of interferon regulatory factor-1 (IRF-1) in the regulation of apoptosis in vascular remodeling; study using IRF-1 null mice
• Regulation of IkappaB Degradation and MCP-1 Expression by SHP-1 VIA AT2 Receptor in Fetal Vascular Smooth Muscle Cells
• Role of ATRAP, novel AT1 receptor associated protein, in the regulation of AT1 receptor-mediated signaling
• Cross Talk between Angiotensin II Type 1 and Type 2 Receptors : Cellular Mechanism of Angiotensin Type 2 Receptor-Mediated Cell Growth Inhibition
• OE-274 A Novel Interacting Molecule with C-terminal of AT1 Receptor as a Potential Modulator of Cardiomyocyte Hypertrophy(Hypertension, basic-1 (H) OE46,Oral Presentation (English),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation
• Higher serum Tenascin-C levels reflect the severity of heart failure, left ventricular dysfunction and remodeling in patients with dilated cardiomyopathy
• The Role of Osteopontin in the Development of Granulomatous Lesions in Lung
• Angiotensin-converting enzyme gene polymorphism in Japanese patients with hypertrophic cardiomyopathy.
• Differential Upregulation of Ca^ Cycling-Related Proteins May Explain the Gender Difference in Hypertrophic Response in CD38 Knockout Mice
• Role of the Angiotensin II Type 2 Receptor in Arterial Remodeling after Wire Injury in Mice
• A novel role of nuclear receptor LXRalpha in the regulation of human renin gene expression
• The serum concentration of infliximab in cases of autologous blood donation for patients with rheumatoid arthritis
• PE-471 The Effect of Pravastatin on ROCK1 in Angiotensin II-Induced Cardiac Fibrosis(Chronic coronary heart disease/Remodeling-3, The 71st Annual Scientific Meeting of the Japanese Circulation Society)
• OE-010 Influence of a 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitor, Pravastatin, on Angiotensin II-Induced Left Ventricular Remodeling(Chronic coronary heart disease/Remodeling-1 (IHD) OE2,Oral Presentation (English),The 70th Anniversary Annu
• FRS-114 Heterogeneous Myocardial Oxidative Metabolism in Patients with Left Bundle Branch Block and Right Ventricular Pacing(Nuclear Cardiology (I) : FRS14)(Featured Research Session (English))
• Influence of Left Ventricular Diastolic Function on the Clinical Course of Patients with Hypertrophic Cardiomyopathy
• Effects of angiotensin II receptor blockers on dementia
• Remote control of brain angiotensin II levels by angiotensin receptor blockers
• Listening to the sound of silence between men and women
• Cardioprotective Role of AT2 Receptor in Post-Infarction Left Ventricular Remodeling
• ATRAP May Inhibit Cardiomyocyte Hypertrophy through the p38-MAPK Pathway (Molecular Biology, Myocardium 2 (M), The 69th Annual Scientific Meeting of the Japanese Circulation Society)
• OJ-521 The Angiotensin II Type 1 (AT1) Receptor-Associated Protein, ATRAP, strictly regulates AT1 Receptor-Mediated Signaling in Cardiac Myocytes(Molecular Biology, Myocardium 2 (M) : OJ64)(Oral Presentation (Japanese))
• Genetic disruption of angiotensin II type 2 (AT2) receptor worsened short-term survival after acute myocardial infarction in mice
• The Evolving Paradigm of Cardiovascular Endocrinology : Renin Angiotensin as a Model System
• New Insight of Angiotensin II Receptor Blocker Treatment in Cardiac Dysfunction Using Angiotensin-Converting Enzyme 2-Deficient Mice
• 1 Roles of Angiotensin II Type 2 Receptor Stimulation in Ischemic Brain(Meet the Expert 4 (ME4) (H),The 70th Anniversary Annual Scientific Meeting of the Japanese Circulation Society)
• 2 Roles of Angiotensin II Type 2 Receptor Stimulation in Ischemic Brain Damage and Cognition(Lifestyle-related Diseases and Signalling Networks in Aging,Topic 7 (TP-7) (H),The 73rd Annual Scientific Meeting of The Japanese Circulation Society)

もっと見る 閉じる

スポンサーリンク